Chest pain is one of the most common reasons for emergency department (ED) visits in developed countries. Whether higher volume EDs have better outcomes, specifically for patients with chest pain, is unknown and pertinent.
C
hest pain is one of the most common reasons for emergency department (ED) visits in developed countries. In the United States, the Centers for Disease Control and Prevention reports that >6 million patients with chest pain are evaluated in EDs each year. 1 Although numerous studies have demonstrated a relationship between the higher physician or hospital volume with better patient outcomes in medical conditions and surgical procedures, [2] [3] [4] little is known about the relationship between ED volume and outcomes for patients presenting to EDs for chest pain assessment. Higher volume EDs may have better outcomes because they may select more appropriate patients with chest pain for discharge and have the ability to establish follow-up appointments and follow-up diagnostic evaluations. In contrast, higher volumes EDs could have worse outcomes because ED crowding is strongly correlated with the number of patients encountered in the EDs, which has been shown to be associated with increase time for diagnosis and treatment, and higher rates of adverse patient outcomes. [5] [6] [7] [8] Understanding whether a volume-outcome relationship exists for patients with chest pain who are discharged from the ED has important policy implications. If higher volume EDs are associated with better outcomes in chest pain care, then it would be essential to consider whether regionalization of care is possible, and to evaluate whether lessons of the high-volume centers can be transferred to lower volume centers to achieve an optimal outcome. Alternatively, if EDs with higher volume are associated with worse outcomes, then the focus should be directed to alleviating overcrowding and further investigating root causes. Accordingly, our first objective was to determine the association between ED chest pain volume with processes of care and outcomes of patients with chest pain who were assessed and discharged. Second, if such a relationship exists, we intended to determine if there was a volume threshold above which an increase in ED volume was no longer associated with a lower adverse outcome.
METHODS

System Context
The Ontario health insurance system provides universal coverage for all essential ambulatory and emergency medical services for all its citizens. Clinical assessments in the ED and in the outpatient setting are provided at no additional cost. The Ontario Drug Benefit program is a government-funded drug benefit program that covers outpatient drug costs for all Ontario residents 65 years or older.
9,10
Data Sources
Data for this study were obtained by linking multiple large population-based databases in Ontario. These databases have been used extensively for clinical research and have been described in detail elsewhere. 11, 12 Briefly, the Canadian Institute for Health Information National Ambulatory Care Reporting System database is a nationwide database that contains information on all ED visits including diagnoses, comorbidities, and disposition decisions. The Canadian Institute for Health Information-Discharge Abstract Database contains information on demographics, comorbidities, and invasive and surgical treatment on all hospitalized patients. The Ontario Health Insurance Plan physician claims database capture data on physician services, such as physician follow-up, diagnostic testing, such as electrocardiograms, stress testing, and echocardiography. The Ontario Drug Benefit database was used to capture outpatient prescription drug use for all residents ≥65 years old. The Ontario Registered Persons Database, which includes vital statistics for all Ontarians, was used to determine mortality after the index event. These datasets were linked using unique encoded identifiers and analyzed at the Institute for Clinical Evaluative Sciences to protect patient confidentiality. The use of data in this project was authorized under section 45 of Ontario's Personal Health Information Protection Act, which does not require review by a Research Ethics Board A waiver of informed consent is permitted under privacy laws in Ontario for the use of administrative data for research purposes. The data, analytic methods, and study materials will not be made available to other researchers for purposes of reproducing the results or replicating the procedure.
Study Population
We included patients ≥40 years and <105 years old, who presented to an ED in Ontario, Canada, with a primary complaint or a primary diagnosis of chest pain and were discharged after ED assessment between April 1, 2008 and March 31, 2014. We excluded patients under 40 years of age because of
WHAT IS KNOWN
• Chest pain is one of the most common reasons for visits to emergency departments. • A relationship between higher volume and improved outcomes has been shown in many conditions. • It is unknown whether chest pain volume in emergency departments is important.
WHAT THE STUDY ADDS
• One of the largest studies included close to 500 000 patients who were evaluated in the emergency departments with chest pain. • Higher emergency department volume of patients with chest pain was associated with lower odds of dying or having recurrent acute coronary syndrome.
• At a certain volume threshold, an increase in volume was no longer associated with reduced outcomes.
• Additional studies are needed to examine reasons for the discrepancies of outcomes in high-and low-volume emergency departments.
their low risk of having coronary artery disease. [13] [14] [15] An upper age limit was also placed to exclude implausible values.
The International Classification of Disease, Tenth Revision (ICD-10) codes (R07.1-R07.4, I20.0, I20.1, I20.8, I20.88, or I20.9) in the Canadian Institute for Health Information National Ambulatory Care Reporting System were used to capture a cohort of patients with chest pain without a diagnosis of myocardial infarction, consistent with prior studies. [13] [14] [15] We excluded patients who had scheduled visits to EDs, transferred in from other acute care hospitals, or had an assessment in pediatric, psychiatric, and very small EDs (<30 chest pain cases per year). We also excluded patients who were not Ontario residents, had invalid Ontario healthcare numbers, or invalid dates of assessment because of the inability to examine their outcomes. For patients who had multiple ED visits during the study period, the initial ED visit was considered the index event.
ED Chest Pain Volume
We calculated ED chest pain volume with very few exclusion criteria so that they are reflective of the clinical experience of each institution. ED chest pain volume was evaluated as a continuous variable, calculated as the average annual number of patients with chest pain evaluated in each ED over the entire duration of the study period.
Processes of Care
We evaluated processes of care for patients with chest pain during ED assessment, including cardiologist consultation and stress testing. We also evaluated physician follow-up by primary care physicians or cardiologists, use of cardiac medications, diagnostic testing, and cardiac invasive procedures within 30 days of ED discharge. For patients >65 years, for whom medication information was available, we assessed prescriptions of cardiac medications (angiotensin-converting enzyme inhibitors/angiotensin receptor blockers, β-blockers, calcium channel blockers, statins, antiplatelet agents, and long-acting nitrates) filed within 30 days of ED discharge. Complete follow-up data were available for all patients through March 31, 2015.
Outcomes
The prespecified primary outcome of our study was a composite end point consisting of all-cause mortality and hospital admission because of acute coronary syndrome (ACS) within 30 days of ED discharge. The diagnosis of ACS included myocardial infarction and unstable angina, identified by ICD-10, disease codes (I20, I21, I22, I23.82, and I24). 16 Additional outcomes of all-cause mortality, all-cause hospitalization, ACS hospitalization, and the composite end point of all-cause mortality or readmission were examined. Outcomes of all events at 1 year were also evaluated.
Statistical Analysis
To facilitate presentation of our results for baseline tables, we categorized ED volume into 4 groups based on quartile of patients in our study cohort (low, low medium, medium, and high volume). Descriptive statistics were used to describe the baseline and clinical characteristics of the entire cohort and to compare patients across ED volume categories. χ 2 tests were used to compare categorical variables, 1-way ANOVA was used to compare continuous variables, and Kruskal-Wallis tests were used to obtain P values for comparison of medians.
Hierarchical logistic models were used to evaluate the relationship between ED chest pain volume and outcomes of interest. 17 The first model adjusted for patient characteristics, selected on the basis of clinical knowledge and prior studies and included: demographics (age, sex, rural residency, and quintile of neighborhood income), cardiac risk factors (diabetes mellitus, hypertension, and dyslipidemia), prior cardiac conditions (unstable angina, myocardial infarction, heart failure, arrhythmia, atrial fibrillation, peripheral vascular disease, and cerebrovascular disease), prior cardiac procedures (percutaneous coronary intervention and coronary artery bypass grafting), medical comorbidities (chronic obstructive pulmonary disease, renal disease, and cancer), and Charlson comorbidity score. In a second model, we further adjusted for hospital characteristics that included teaching hospital status and availability of cardiac invasive procedure capability. In both models, ED volume was treated as a continuous variable and was log-transformed using natural logarithm. ED volume was log-transformed for 2 reasons: first, for consistency with previous studies examining the existence of a threshold effect in the volume-outcome studies 4 and second, log-transformation results in a model in which the effect of increasing volume is attenuated as volume increases, which likely better represents the trajectory of volume impact (ie, increasing volume from 100 to 200 patients has a stronger effect on outcomes than increasing volume from 1000 to 1100 patients). The mean hospital-specific log odds of the outcome at each ED were calculated by computing the mean of the model-derived patient-specific estimates of the log odds of the outcome for patients seen at that ED. A scatter plot was then constructed to graphically depict the relationship between hospital-specific outcomes with the observed log odds of annual chest pain volume at each ED.
We also estimated the volume threshold above which an increase in ED volume was not associated with a reduction in the odds of an adverse outcome by determining the change in the adjusted odds ratio (OR) associated with increasing the ED chest pain volume by 100 cases. 4 We defined the volume threshold as the annual ED volume for which the relative change in the adjusted odds of the outcome associated with an increase of 100 patients with chest pain would be <0.01 (ie, OR >0.99). To characterize the variation of the estimated threshold, we used bootstrapping techniques and replicated this analysis in 500 bootstrap samples to obtain 95% CIs for the volume threshold. 18 We performed additional analyses categorizing patients into 2 groups based on the presence of diabetes mellitus or prior cardiovascular comorbidities. This predetermined analysis was informed by our prior studies demonstrating potential treatment differences in patients with chest pain with different baseline risks. 13, 14 We defined high-baseline cardiovascular risk as a history of any the following diabetes mellitus, chronic atherosclerosis, unstable angina, myocardial infarction, heart failure, atrial fibrillation, ventricular arrhythmias, peripheral vascular disease, cerebrovascular disease, or cardiac interventions (percutaneous coronary intervention, coronary artery bypass grafting surgery, or implantable cardiac defibrillator). 13, 14 Patients at lower baseline risk were defined to be the absence of these conditions. Statistical significance was indicated by a 2-tailed value of P<0.05. All analyses were performed with SAS version 9.1.3 (SAS Institute Inc, Cary, NC).
RESULTS
Study Sample
The construction of our study sample is shown in Figure To create a cohort for outcome assessment, we further excluded 155 952 visits because patients were hospitalized after ED presentation, 148 569 encounters because of multiple ED presentations, 2627 visits because of transfers, 1651 visits because of scheduled visits to the ED, and 201 visits that had no followup. After these exclusions, our study sample included 498 291 patients presenting to 179 EDs.
Characteristics by ED Chest Pain Volume
Baseline characteristics of the study sample stratified by ED chest pain volume are shown in Table 1 . The mean age of our study cohort was 59 years, 46.7% were men, 21.4% had diabetes mellitus, and 5.6% had a history of myocardial infarction. The median annual ED chest pain volume per year was 449 (interquartile range, 250-651) for low-volume EDs, 1232 (interquartile range, 1110-1424) for low-medium volume EDs, 1958 (interquartile range, 1807-2018) for medium-volume EDs, and 2651 (interquartile range, 2570-2726) for high-volume EDs. There were 118 EDs comprising the low-volume group, 29 EDs in the low-medium volume group, 18 EDs in the medium-volume group, and 14 EDs in the high-volume group. Hospitalization rates of patients with chest pain did not differ substantially, in that 11%, 12.2%, 12.2%, and 11.2% of the patients with chest pain were hospitalized from low, low-medium, medium, and high-volume EDs in the volume cohort, respectively.
Patients evaluated in high-volume EDs had the highest rates of diabetes mellitus, hypertension, and dyslipidemia compared with patients evaluated in other EDs.
Alternatively, patients evaluated in low-volume EDs were slightly older, had the more chronic obstructive pulmonary disease, and were most likely to be residing in a rural residence (Table 1) . Hospital characteristics differed by ED volume that we observed that the lowest rate of teaching status and cardiac invasive capability in the lowest volume EDs.
Association of ED Volume and Processes of Care
Patients who were assessed in high-volume EDs had significantly higher rates of cardiologist consultation during the initial ED assessment (47.6%) compared with 26.7% in low-volume EDs (Table 1) . Stress testing was infrequently used in all Ontario EDs during chest pain visits. Although patients with chest pain had similar rates of physician follow-up after ED discharge, those presented to high-volume EDs were significantly more likely to have cardiologist follow-up while patients presenting to low-volume EDs were much more likely to be evaluated by a primary care physician. For example, in the highvolume EDs, 61.8% of patients were evaluated by a cardiologist and 73% by a primary care physician within 30 days; and in the low-volume EDs, only 35.4% were evaluated by a cardiologist and 80.6% by a primary care physician ( Table 1 ). The use of echocardiography and stress testing was 16.5% and 29.1% after discharge from high-volume EDs versus 8.6% and 16.1% after discharge from low-volume EDs (all P<0.001). In high-volume EDs, 2.2% of patients had cardiac catheterization within 30 days, compared with 1.8% who had cardiac catheterization in low-volume EDs.
Significantly higher rates of cardiac medication prescriptions in the first 30 days were also seen in highvolume EDs as compared with low-volume EDs. For example, prescription rates of angiotensin-converting enzyme inhibitors/angiotensin receptor blockers, β-blockers, statins were 28.1%, 19.5%, and 26.4% in the high-volume EDs as compared with 25.4%, 18.6%, and 23.6% in the low-volume EDs.
Association of ED Volume and Outcomes
At 30 days, unadjusted rates of death or ACS were 1% and 0.8% among patients discharged from the low-volume and high-volume EDs; and at 1 year, rates of death or ACS were 4.4% and 3.1%, respectively ( Table 2) . Rates of all-cause hospitalizations at 30 days were 4.2% and 3.6% in the low, and highvolume EDs, respectively. At 1 year, unadjusted rates of death, ACS hospitalization rates, all-cause hospitalization, and their composites followed a graded pattern with lowest event rates observed in the high- volume EDs and the highest event rates observed in the low-volume EDs. Figure 1 depicts the association between ED volume (log-transformed) and the adjusted log odds of experiencing death or ACS within 1 year at each ED, demonstrating decreasing adjusted log odds of adverse outcomes with increasing ED volume in a relatively linear fashion. Table 3 shows the unadjusted, patient-adjusted, and patient-andhospital-adjusted association between ED chest pain volume and adverse outcomes. In the fully adjusted model, the adjusted OR for death or ACS at 30 days was 0. Each data point represents the hospital-specific log odds of the outcome at each ED (y axis) vs observed annual chest pain volume at each ED in log scale (x axis), generated by the full hierarchical logistic models that adjusted for patient and hospital characteristics. The line represents the fitted regression line. MI indicates myocardial infarction.
Outcomes of Patients With Chest Pain According to Different Baseline Risks
The baseline characteristics, processes of care, and outcomes of high-and low-baseline risk patients, categorized by ED volume, are shown in Tables I through  III in the Data Supplement. The adjusted association between ED chest pain volume and adverse outcomes for these patient subgroups are shown in Table 3 for 30-days outcomes and Table IV in the Data Supplement for 1-year outcomes. Findings in this subgroup analysis were consistent with the overall results except for the fact that larger absolute difference in outcome rates was seen among high-risk patients by ED volume. For example, in patients at higher baseline risk, rates of death or ACS at 30 days were 1.8%, 1.5%, 1.4%, and 1.4% in the low, low-medium, medium, and highvolume EDs, respectively (Table III in the Data Supplement). In the low-risk patients, rates of primary outcomes were 0.7%, 0.6%, 0.5%, and 0.5% from low to high-volume EDs (Table III in (Table 3) . Figure 2 shows the relationship between changes in the adjusted OR for death or ACS associated with an increase of ED volume by 100 patients to illustrate the potential threshold effect. The change in adjusted OR was largest at smaller volumes, and the marginal benefit became increasingly smaller at higher ED chest pain volumes. At an ED chest pain volume of 100 patients per year, increasing the annual volume by 100 was associated with a 6.0% reduction in the odds of experiencing death or ACS within 1 year. We estimated that at an annual ED chest pain volume of 1400 (95% CI, 910-1900), a further increase in ED volume of 100 would be associated with an odds ratio of >0.99. We also estimated that the number needed to treat of 484 patients to prevent death or hospitalization for ACS at 30 days when assuming ED indicates emergency department; and MI, myocardial infarction. *Model 1 adjusted for age, sex, rural status, income quintile, diabetes mellitus, hypertension, dyslipidemia, angina, MI, heart failure, arrhythmia, peripheral vascular disease, cerebrovascular disease, chronic obstructive pulmonary disease, renal disease, cancer, Charlson index, and prior coronary revascularization. Model 2 adjusted for variables in Model 1+hospital characteristics (teaching hospital and invasive capability). Odds ratio estimate per each unit increase in the log of volume.
Volume Threshold Effect of ED Chest Pain Volume and Outcomes
†High-baseline cardiovascular risk as a history of any the following terms: diabetes mellitus, chronic atherosclerosis, unstable angina, MI, heart failure, atrial fibrillation, ventricular arrhythmias, peripheral vascular disease, cerebrovascular disease, or cardiac interventions. Low-baseline risk was defined as the absence of any of these conditions. patients were treated in the high-volume EDs from the low-volume EDs.
Subgroups Analysis on Urban Residents
We also performed an additional analysis examining the relationship of ED chest pain volume and outcomes among 424 898 patients residing in urban locations and found similar results as our entire cohort that the adjusted ORs of ED volume outcome and death or ACS were 0.83 (95% CI, 0.77-0.90) at 30 days and 0.89 (95% CI, 0.85-0.94) at 1 year (Table V in 
DISCUSSION
In this large population of patients with chest pain who were assessed in the ED and discharged, we found a significant association between higher ED volumes and lower mortality or ACS hospitalization after discharge. Although the absolute difference in event rates was small at 30 days across ED volume categories, the magnitude of difference diverged over time such that a 1.3% difference in death or ACS was observed comparing the low and high-volume EDs at 1 year. The association was consistent among patients at different baseline risks, those discharged from rural or urban hospitals, and across all the endpoints. We also observed a volume threshold at 1400 chest pain cases per year for which an increase in the ED volume was no longer associated with increased risk of worse outcomes. Further efforts are needed to examine reasons for the discrepancies of outcomes in high-and lowvolume EDs.
These findings extend our current knowledge about the potential impact of ED volume on patient outcomes in contemporary clinical practice because only limited literature exists. [19] [20] [21] A study from 2006 found that higher ED volumes were associated with a lower likelihood of missed myocardial infarction. 19 It was conducted before the widespread use of troponin, and the outcomes difference was thought to be related to the lack of access to troponin assays in smaller volume EDs. Kocher et al 20 found lower in-hospital mortality among the 8 most commonly hospitalized conditions in the United States when patients were admitted from higher volume EDs. However, it was difficult to disentangle the impact of ED volume and hospital volume because they were highly correlated. A recently published study found that patients with atrial fibrillation treated at higher volume EDs had a lower risk of readmission and repeat visits to the ED. 21 By focusing on a cohort of chest pain who were discharged, and who are typically at lower risk than those admitted to hospital, we were able to examine the impact of decision-making in the ED as opposed to the influence of in-hospital care on outcomes because of the volume-outcome relationship of hospitalized patients has been clearly established. 20, 22 Although it is difficult to fully disentangle the reasons why patients with chest pain evaluated in high-volume EDs had better outcomes, several factors deserve con- sideration. First, it is possible that initial cardiology consultations in higher volume EDs enabled the outpatient referral process and engagement for patients for ambulatory testing and treatment after discharge. In contrast, primary care physicians evaluating patients after ED discharge without initial specialist consultation may be falsely reassured about the negative ED workup, are unaware the need to perform additional diagnostic testing, and potentially have inadequate access of obtaining outpatient specialist care or diagnostic testing. Indeed, we found higher rates of cardiac medication prescriptions, cardiac catheterization use within 30 days, and almost a 2-fold higher rate of echocardiography, ischemic evaluation, and cardiologist visits comparing high-volume EDs verses and lowvolume EDs. Other reasons to explain discrepancy in specialist follow-up included differences in discharge planning across EDs and regional difference in access to specialist care after discharge. Second, given the fact that a large proportion of patients evaluated in lowvolume ED resided in rural areas, we were uncertain whether this volume-outcome relationship could simply be explained by differences in geographic access. Accordingly, we performed an additional analysis that focused on patients in the urban area and found similar finding that higher volume EDs were associated with better outcomes.
Our findings have policy implications on how best to manage patients with chest pain in the future. A huband-spoke model already exists in invasive cardiac care in Canada, where patients are transferred to regional invasive centers for their procedures, and then repatriated back to the referral hospitals. 23, 24 However, given the vast number of patients with chest pain encountered in Ontario and the fact that many smaller volume EDs are locating in more geographically remote area, regionalization of care for patients with chest pain workup is likely not feasible. Instead, it may be more possible for clinicians working in smaller volume EDs to establish partnerships with cardiac centers to gain specialist through econsultation, telemedicine, or rapid referral centers to streamline those who need more urgent cardiac diagnostic testing and treatment. Although we await further studies to understand the potential cost implication of more intensive care for these patients, a system to monitor access of cardiac evaluation after ED evaluation would be beneficial to ensure equity of care across Ontario.
Several potential limitations of our study merit consideration. First, although discharge decisions from EDs after chest pain assessment are guided by diagnostic tests, such as electrocardiographic findings or troponin values, it is possible that outcome differences may be a result of case mix difference because EDs may have different thresholds for discharge. 25 However, we observed similar characteristics of our study cohort, and in fact, patients with more cardiac comorbidities were being discharged from higher volume EDs. We also examined the rates of discharge after assessment across ED volume categories and found discharge rates were at around 80%. Nevertheless, our database lacked clinical details, such as chest pain characteristics or ECG changes of patients. In addition, we did not have information on the characteristics of ED physicians and additional hospital characteristics beyond teaching status and cardiac invasive capability. Second, even adjusting for patient characteristics and variation in hospital characteristics, such as their cardiac capability to perform invasive procedures, we identified the importance of ED volume on long-term outcomes. However, the volume is likely a surrogate of different factors that are associated with improved outcomes. Accordingly, simply changing ED volume without improving access to specialist care or diagnostic testing is unlikely to improve process of care and outcomes. Future work is needed to first understand the key factors associated with adverse outcomes after ED discharges of patients with chest pain, and the extent to which they can explain the variation in the volume outcomes. Third, ischemic evaluation was infrequently performed in the ED before patient discharge. Although our results may not be generalized to areas that perform routine ischemic testing before discharge, the impact of routine stress testing in the ED is likely low as a study showed <1% of these patients received subsequent revascularization. 26 Finally, although the codes we used to identify patients with chest pain had been used in other studies, 13-15 they have not been validated because chest pain diagnosis is heterogeneous without a gold standard for diagnosis.
In summary, higher volume EDs were associated with lower rates of mortality and ACS hospitalization for patients with chest pain after assessment. This relationship was the most prominent among patients evaluated in low-volume EDs and attenuated to a point where improvements in outcomes with increasing volume were no longer observed once ED volumes exceeded 1400 cases per year. Our findings should be used to inform efforts to understand the root causes of why EDs with lower chest pain volume had worse outcomes so that solutions could be derived to improve outcomes of patients with chest pain in the future. 
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